Anavex Life Sciences Corp expected to post a loss of 19 cents a share - Earnings Preview

Anavex Life Sciences

05/05/2023 19:36

* Anavex Life Sciences Corp  AVXL.OQ   AVXL.O  is expected
to show
no change in quarterly revenue when it reports  results on May
9. 
    * 
    * ​Refinitiv's mean analyst estimate for Anavex Life
Sciences Corp
is for a loss of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Anavex Life
Sciences Corp is $47​, above​ its last closing price of $8.40.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.20       -0.19      -0.17     Beat    10.5
 Sep. 30 2022  -0.16       -0.16      -0.18     Missed  -11.1
 Jun. 30 2022  -0.15       -0.15      -0.16     Missed  -5.3​
 Mar. 31 2022  -0.17       -0.17      -0.14     Beat    16.4
 ​​Dec.        -0.15       -0.15      -0.14     Beat    9.7
 31 2021                                                
 Sep. 30 2021  -0.16       -0.15      -0.15     Met     -2.3​
 Jun. 30 2021  -0.13       -0.13      -0.14     Missed  -4.5
 Mar. 31 2021  -0.14       -0.14      -0.12     Beat    15.8
 This summary was machine generated May 5 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated